COVID-19 vaccinations summary

Second Boosters Administered 1,034,221
Total Doses Administered 12,973,845
First Boosters Administered 2,773,597
Percentage of 12+ who have completed primary course 86.7%
Percentage of eligible 50+ who have received second booster 56.7%
Percentage of eligible 18+ who have received first booster 74.1%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

The person view includes all people that are currently alive and in the latest Health Service User (HSU) population. The current HSU in use is the financial year 2022/23 HSU (FY2022/23 HSU). The HSU is an estimate of the population using the health system in New Zealand. A person is included in the HSU if they use health services (including births and deaths) in the reference period, or are enrolled in a primary health organisation (PHO) during the reference period. The reference period for the FY2022/23 HSU is: 1/7/2022 to 30/6/2023.

Total vaccinations

  Vaccinations last week Cumulative total
First dose 419 4,042,448
Second dose 44 3,986,810
Booster 1 196 2,773,597
Booster 2 1,032 1,034,221
Booster 3+ 6,374 705,197
Paediatric First Dose 14 272,302
Paediatric Second Dose 4 158,894
Infant First Dose 0 166
Infant Second Dose 1 127
Infant Third Dose 1 83
Total doses 8,085 12,973,845

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Friday 16 February 2024.
  • Vaccinations last week:  Over the 7 days up to and including Friday 16 February 2024.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 711 252,340 64,191
Pacific Peoples 476 147,016 28,198
Asian 1,402 439,988 63,625
European/Other 4,342 1,799,365 685,978
Unknown 15 12,326 3,517
Total 6,946 2,651,035 845,509

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
18 to 34 162,611 38,503 23.7%
35 to 49 619,353 121,652 19.6%
50 to 64 721,976 290,236 40.2%
65+ 769,283 555,273 72.2%


This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings. 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation